Differential expression of the G-protein-coupled formyl peptide receptor in melanoma associates with aggressive phenotype

American Journal of Dermatopathology

Volumn 35, Issue 2, 2013, Pages 184-190

  Chakravarti, Nitin ^a   Peddareddigari, Vijay G R ^a   Warneke, Carla L ^a   Johnson, Marcella M ^a   Overwijk, Willem W ^a   Hwu, Patrick ^a   Prieto, Victor G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

FPR; FPRL1; Melanoma; Nevi; Prognosis

Indexed keywords

FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER REGRESSION; CLINICAL FEATURE; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTATIC MELANOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKIN ULCER; SKINFOLD THICKNESS; TISSUE MICROARRAY;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; PHENOTYPE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878919169     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31825b2506     Document Type: Article

References (18)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front Biosci. 2006;11:1244-1254.
3. Gaggioli C, Sahai E. Melanoma invasion - current knowledge and future directions. Pigment Cell Res. 2007;20:161-172.
4. Young D, Waitches G, Birchmeier C, et al. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell. 1986;45:711-719.
5. Li S, Huang S, Peng SB. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int J Oncol. 2005;27: 1329-1339.
6. Lee HJ, Wall B, Chen S. G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res. 2008;21:415-428.
7. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol. 2002;23:541-548.
8. Rondepierre F, Bouchon B, Papon J, et al. Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. Biochim Biophys Acta. 2009;1794:61-69.
9. Ivan D, Prieto VG. An update on reporting histopathologic prognostic factors in melanoma. Arch Pathol Lab Med. 2011;135:825-829.
10. Chakravarti N, Lotan R, Diwan AH, et al. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res. 2007;13:4817-4824.
11. Zhou Y, Bian X, Le Y, et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst. 2005;97: 823-835.
12. Chen DL, Ping YF, Yu SC, et al. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells. Biochem Biophys Res Commun. 2009;381:448-452.
13. Kefford R, Beith JM, Van Hazel GA, et al. A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma. Invest New Drugs. 2007;25: 247-252.
14. Coffelt SB, Tomchuck SL, Zwezdaryk KJ, et al. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Mol Cancer Res. 2009;7: 907-915.
15. Kam AY, Tse TT, Kwan DH, et al. Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells. Cell Signal. 2007;19:2106-2117.
16. Kanda N, Ishikawa T, Kamata M, et al. Increased serum leucine, leucine-37 levels in psoriasis: positive and negative feedback loops of leucine, leucine-37 and pro- or anti-inflammatory cytokines. Hum Immunol. 2010;71:1161-1171.
17. 2+-dependent mechanism. Cancer Res. 2010;70: 5607-5617.
18. Babbin BA, Lee WY, Parkos CA, et al. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem. 2006;281:19588-19599.